Constipation, a common complaint in clinical practice, often poses a diagnostic and therapeutic challenge for physicians. A comprehensive approach is necessary to understand its multifaceted etiology and devise an effective management plan.
Constipation can be primary, due to intrinsic colonic or anorectal dysfunction, or secondary to systemic diseases, medications, or lifestyle factors. A thorough history and physical examination, supplemented by targeted investigations, can help identify the underlying cause. Rome IV criteria, a set of symptom-based guidelines, are valuable in diagnosing functional constipation.
Management should be tailored to the underlying cause. For functional constipation, initial strategies include lifestyle modifications, such as increased dietary fiber and fluid intake, regular exercise, and timely toilet habits. If these measures are insufficient, pharmacological interventions such as osmotic and stimulant laxatives, prokinetic agents, or selective serotonin reuptake inhibitors may be considered.
Chronic constipation, defined as symptoms persisting for at least three months, may require further diagnostic evaluation, including anorectal manometry, colonic transit studies, or defecography. Management may involve biofeedback therapy, surgical interventions, or novel treatments such as sacral nerve stimulation and percutaneous tibial nerve stimulation.
Constipation is a complex condition requiring a comprehensive, individualized approach for effective diagnosis and management. Understanding its etiology, utilizing appropriate diagnostic tools, and tailoring treatment to the patient's specific needs are key to achieving optimal outcomes. Ongoing research into novel diagnostic and therapeutic strategies promises to further enhance our ability to manage this common, yet often challenging, condition.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation